Macular Degeneration and MicroCurrent therapy

128 million people worldwide suffer from Macular Degeneration and the vast majority have few treatment options.  However, a growing body of scientific evidence indicates that microcurrent stimulation is able to stabilize or improve the vision of many people loosing their eyesight to macular degeneration.

Healthcare professionals around the world use microcurrent stimulation to treat a variety of injuries and conditions. With a few exceptions, microcurrent stimulators are considered safe when used for their intended purpose.  Medical doctors in the U.S. have used microcurrent stimulation for several years as an “off-label” treatment. They report measurable vision improvement in over 60% of their patients. A clinical trial is underway to receive formal FDA approval.

The exact process or mechanism is unknown. Many believe microcurrent stimulation improves blood flow to the retina, thereby increasing the supply of vital nutrients and promoting the removal of harmful waste products. Others speculate that photoreceptors in the macula are given a needed boost with the production of ATP (adenosine triphosphate), a compound known to transport energy to cells.

Expectations

First, it should be understood that microcurrent stimulation is not a cure for macular degeneration.  Not everyone benefits.  Positive results are immediate for some and take months for others.  Effects are temporary, requiring repeated treatments to maintain the benefits. People with the “dry” form of macular degeneration have the best results.  People with a long history of the “wet” form or who have received photocoagulation laser therapy may experience poor results due to scarring.

Depending on the severity of other common eye disorders like cataracts, astigmatism, myopia and presbyopia, the first noticeable improvement is typically the ability to read smaller print.

Read about the History of MicroChannel Therapy